NLA Scientific Statement on Statin Intolerance: A New Definition and Key Considerations for ASCVD Risk Reduction in the Statin Intolerant Patient
By
National Lipid Association
FEATURING
Mary Katherine Cheeley
August 11, 2022
Login to view comments.
Click here to Login